Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?

被引：11

作者：

Liu, Fei ^{[1
]}

Wang, Jingjing ^{[1
]}

Ye, Qing ^{[2
]}

Fu, Haidong ^{[1
]}

Mao, Jianhua ^{[3
]}

机构：

[1] Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Sch Med, Dept Nephrol,Childrens Hosp, Hangzhou, Zhejiang, Peoples R China

[2] Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Sch Med, Dept Clin Lab,Childrens Hosp, Hangzhou, Zhejiang, Peoples R China

[3] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 04期

关键词：

anemia chronic kidney disease; polycystic kidney disease;

D O I：

10.1681/ASN.2020111664

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1005 / 1005

页数：1

共 4 条

[1] Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan [J].

Akizawa, Tadao ;

Iwasaki, Manabu ;

Yamaguchi, Yusuke ;

Majikawa, Yoshikatsu ;

Reusch, Michael .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07) :1628-1639

[2] Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial [J].

Akizawa, Tadao ;

Iwasaki, Manabu ;

Otsuka, Tetsuro ;

Reusch, Michael ;

Misumi, Toshihiro .

ADVANCES IN THERAPY, 2019, 36 (06) :1438-1454

[3] Role of oxygen and the HIF-pathway in polycystic kidney disease [J].

Buchholz, Bjoern ;

Eckardt, Kai-Uwe .

CELLULAR SIGNALLING, 2020, 69

[4] HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease [J].

Kraus, Andre ;

Peters, Dorien J. M. ;

Klanke, Bernd ;

Weidemann, Alexander ;

Willam, Carsten ;

Schley, Gunnar ;

Kunzelmann, Karl ;

Eckardt, Kai-Uwe ;

Buchholz, Bjoern .

KIDNEY INTERNATIONAL, 2018, 94 (05) :887-899

← 1 →